Hypersensitivity reaction during prolonged use of piperacillin/tazobactam in treatment of osteomyelitis.
R
R
Behbahani
J R
JR
Kostman
D004342:Drug Hypersensitivity / Q000503:physiopathology*; D004359:Drug Therapy, Combination / Q000009:adverse effects* / Q000627:therapeutic use; D004791:Enzyme Inhibitors / Q000009:adverse effects / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008875:Middle Aged; D010019:Osteomyelitis / Q000150:complications* / Q000188:drug therapy; D010397:Penicillanic Acid / Q000009:adverse effects / Q000031:analogs & derivatives / Q000627:therapeutic use; D010406:Penicillins / Q000009:adverse effects / Q000627:therapeutic use; D010878:Piperacillin / Q000009:adverse effects / Q000627:therapeutic use; D000078142:Tazobactam; D065093:beta-Lactamase Inhibitors
D004791:Enzyme Inhibitors; D010406:Penicillins; D065093:beta-Lactamase Inhibitors; D010397:Penicillanic Acid; D000078142:Tazobactam; D010878:Piperacillin